Since most cancers have multiple genetic alterations and molecular abnormalities, it is seldom very useful by using therapeutics of only one anticancer drug owing to refractory and drug resistance of cancer tissues. It has a long time consensus that anticancer drug cocktail instead single drugs might dramatically promote the control of cancer progresses and metastasis in most clinical cancer tr...

The National Cancer Institute's (NCI's) human tumor cell line panel for screening potential new anticancer drugs is now operational (/). Its implementation and the demonstration of its feasibility represent a technical and organizational tour de force. The rationale for the change in the primary screen from leukemias in mice to the array of 60 human cancer cell lines was earlier debated in cont...

Drug development as a sensitive thermometer represents the scientific and technical power-engines for any countries. As a result, drug manufacture (highly competitive area) is pillar industry for small-range of developed countries and highest medical expenditures worldwide. Nonetheless, new anticancer drug discovery, development and manufacture were entering into bottleneck stage two decades ag...

in this study, the folate decorated biodegradable poly (lactide-co-glycolide) (plga) nanoparticles were developed for tumor targeting of anticancer agents. due to the overexpression of the folate receptor on tumor surface, the folate has been efficiently employed as a targeting moiety for various anticancer agents to avoid their non-specific attacks on normal tissues and also to increase their ...

Smart Anticancer Drug Nanocarriers In article number 2206813, Neralla Vijayakameswara Rao, Wei-Hung Chiang, and co-workers develop a plasma engineering of nitrogen-doped graphene quantum dot (NGQD) hydrogels with robust, porous photoluminescence properties. The presence NGQDs in the hydrogel can accelerate improve loading capacity anticancer drug doxorubicin via π-π interaction, exhibits stable...

It has been an absolute pleasure to be the guest editor of this Special Issue! As title indicates, topic is on advances made against cancer [...]